How to Heal the Ailing FDA

From the WaPo we learn there is a shortage of monoclonal antibodies, so the feds will take over distribution.  Hmm.  We don’t know anything about long-term side effects of monoclonals. Monoclonal antibodies are an effective and very expensive product if used in the first week of illness–just like hydroxychloroquine, which the feds (and most states) have…

It is difficult for me to believe that two thirds of the US (according to a Harris poll) are favorably inclined to the pharmaceutical industry, up 30 percentage points since January 2020, just before the pandemic. Do you believe it? Who do you trust:  Common sense, or the media’s experts? Surely most Americans have by…

Pharmaceutical companies conduct pre-clinical (without people) and clinical research (utilizing human subjects) to understand the effects of drugs they are developing. Until now, even though the research often involves human voluntary subjects who may not be compensated for their participation, the findings of the research have been considered proprietary, or owned by the research sponsor….

 In Ireland, nobody pays. I updated my knowledge of the United States’ CICP on April 16, through a seminar put on by the RAND Corporation’s Justice Policy program. In the US, you have the right to apply to the Countermeasures Injury Compensation Program.  Of the 700 plus people who have applied, 500 cases have been…

My friend Mark Crispin Miller has urged me to be more specific about why I am concerned about the safety of swine flu vaccines in the US. In a nutshell: 1. Newness I am always concerned about new drugs and vaccines. A former FDA Commissioner, Dr. Jane Henney, once said she did not use drugs…

According to CDC, weekly swine flu hospitalizations began dropping the last week of October; the death rate also dropped. UPDATE: I called CDC on Monday, November 9, to ask why this wasn’t updated, as usually occurs on Fridays. I was told that 15 deaths (swine flu) and 3 deaths (non-subtyped influenza A) were reported last…